FDA Adverse Event Injury Summary report: N

LOGIC CR TIB INSERT STD, SZ 3, 9MM

MDR report key: 20146271 · Received September 5, 2024

Report

Report Number
1038671-2024-03311
Event Type
Injury
Date Received
September 5, 2024
Date of Event
August 25, 2023
Report Date
September 5, 2024
Manufacturer
EXACTECH, INC.
Product Code
JWH
UDI-DI
10885862174345
PMA / PMN Number
K111400
Adverse Event
Yes
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
FL, US
Reporter Occupation
003

Narratives

Additional Manufacturer Narrative · 0

D10 CONCOMITANT DEVICES 4657797, 02-012-45-3030 - LGC TIBIAL FIT TRAY CEM SZ 3F/3T. 4787824, 02-010-03-0330 - LOGIC CR FEMORAL CEM RIGHT SZ 3. 4852381, 200-02-32 - THREE PEG PATELLA 32MM. THE PRODUCT ASSOCIATED WITH THE REPORTED EVENT IS WITHIN THE SCOPE OF RECALL Z-0021-2022; HOWEVER, THERE IS INSUFFICIENT INFORMATION TO EVALUATE WHETHER THE SUBJECT ISSUE OF THE RECALL WAS A CAUSE OR CONTRIBUTOR TO THE REPORTED EVENT. THE DEVICE WAS NOT RETURNED FOR EVALUATION AND NO MEDICAL OR OTHER RECORDS CONTAINING TREATMENT INFORMATION OR PATIENT INFORMATION HAVE BEEN RECEIVED; THEREFORE, THE REPORTED EVENT CANNOT BE CONFIRMED, NOR CAN THE CIRCUMSTANCES OR POTENTIAL CAUSES OR CONTRIBUTORS TO THE ALLEGED EVENT BE EVALUATED. SHOULD ADDITIONAL, MATERIAL INFORMATION BECOME AVAILABLE THAT PERMITS MORE ANALYSIS OR CONCLUSIONS, A SUPPLEMENTAL REPORT WILL BE FILED ACCORDINGLY.

Description of Event or Problem · 0

IT WAS REPORTED THAT APPROXIMATELY 74 MONTHS AFTER A RIGHT TOTAL KNEE REPLACEMENT PROCEDURE, THE PATIENT HAS EXPERIENCED PROSTHESIS WEAR, PAIN, DISCOMFORT, SWELLING, GAIT IMPAIRMENT, POOR BALANCE AND EMOTIONAL DISTRESS. NO FURTHER ISSUES OR COMPLICATIONS WERE REPORTED. NO ADDITIONAL INFORMATION IS AVAILABLE.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1887144 LOGIC CR TIB INSERT STD, SZ 3, 9MM PROSTHESIS, KNEE, PATELLOFEMOROTIBIAL, SEMI-CONSTRAINED, CEMENTED, POLYMER/METAL JWH EXACTECH, INC. UNK 10885862174345

Patients

Seq Age Sex Outcome Treatment
1 NA Female Hospitalization| R SEE H11.